Table 2 Association of BAF250a (ARID1A) expression with clinico-pathological features in ovarian carcinomas
Characteristics | All cases n (%) | BAF250a expression n (%) | P-valuea | |
|---|---|---|---|---|
Negative | Positive | |||
All carcinomas | 129 (100%) | 29 (23) | 100 (78) | |
Age at diagnosis | 0.004 | |||
⩽60 years | 63 | 21 (33) | 42 (67) | |
>60 years | 66 | 8 (12) | 58 (88) | |
Histological type | 0.003 | |||
Clear cell | 23 | 5 (22) | 18 (78) | |
Endometrioid | 28 | 13 (46) | 15 (54) | |
Serous | 63 | 7 (11) | 56 (89) | |
Mucinous | 15 | 4 (27) | 11 (73) | |
Tumor stage (n=128) | 0.008 | |||
PT1 | 31 | 10 (32) | 21 (68) | |
PT2 | 15 | 7 (47) | 8 (53) | |
PT3 | 82 | 12 (15) | 70 (85) | |
Nodal stage (n=94) | 0.045 | |||
0 | 60 | 18 (30) | 42 (70) | |
1 | 34 | 4 (12) | 30 (88) | |
FIGO stage (n=123) | 0.005 | |||
1 | 30 | 11 (37) | 19 (63) | |
2 | 9 | 5 (56) | 4 (44) | |
3 | 46 | 8 (17) | 38 (83) | |
4 | 38 | 4 (11) | 34 (90) | |
Tumor grade | 0.201 | |||
1 | 23 | 8 (28) | 15 (65) | |
2 | 51 | 12 (24) | 39 (77) | |
3 | 55 | 9 (16) | 46 (84) | |
Residual disease (n=87) | 0.006 | |||
R0 | 25 | 10 (40) | 15 (60) | |
R1 | 27 | 6 (22) | 21 (78) | |
R2 | 34 | 2 (6) | 32 (94) | |
